Trends in Healthcare Comms: An Interview with John Gisborne of FleishmanHillard Fishburn

John, could you please give us an introduction to your current role, as well as a bit about your background?   I currently oversee the European healthcare function at FleishmanHillard, we are a global communications firm of 3,000 people worldwide. Healthcare is one of our most important sectors. I started my career as a biochemist, … Continue reading “Trends in Healthcare Comms: An Interview with John Gisborne of FleishmanHillard Fishburn”

The Internet of Things: Leveraging the New Industrial Revolution

The media tends to reiterate that the Internet of Things (IoT) is a game-changer for every industry, and the conversation on this topic is becoming livelier and livelier across various channels. Those striving to leverage IoT should be familiar with the topics and companies driving the IoT coverage. Analysing the top publications globally, we discovered … Continue reading “The Internet of Things: Leveraging the New Industrial Revolution”

Identifying Key Opinion Leaders in Pharma Through Influencer Network Analysis (INA)

Key opinion leaders (KOLs) undoubtedly play a very important role in the life sciences industry. Pharma companies typically engage them during the later stages of clinical trials and during drug commercialisation.

Trends in Telco PR: 5G in the Media

Telecommunications companies aiming to leverage 5G are currently in the process of positioning themselves as the top players in the new field. Their PR priority is to be perceived as first-movers, innovators, critical for digital transformation and fundamental for IoT projects. This can be achieved by designing a data-driven communications strategy. Utilising our media analytics … Continue reading “Trends in Telco PR: 5G in the Media”

Meat Alternatives: Cooking Up a Market Disruption

The meat substitutes market is gaining momentum, driven by lively debates in the media, and many big food companies want to take a bite. Analysing the media coverage, we found that the most widely discussed topics are ethics and animal rights, research, regulation and policy, health aspects, environmental issues, product development and business models. In … Continue reading “Meat Alternatives: Cooking Up a Market Disruption”

PR Measurement in Pharma: The Key to Effective Communication Strategies

In the dawn of AMEC’s Measurement Month, a global programme of activities shining the spotlight on the importance of PR measurement, we thought we could highlight the immense value of PR measurement by surveying its applications in an industry suffering from a growing trust problem – pharma. The reputation of pharmaceutical companies depends on the … Continue reading “PR Measurement in Pharma: The Key to Effective Communication Strategies”

Cannabis-Infused Drinks: Exploring the New Beverage Trend

As the global soft-drink and alcohol consumption slows down, a growing number of companies think of cannabis beverages as a new growth vector. However, marketing cannabis-infused products could bring some reputational risks. An effective PR campaign can’t afford to ignore influencers with a well-established authority on this controversial subject. Using our media analytics tools, we … Continue reading “Cannabis-Infused Drinks: Exploring the New Beverage Trend”

Financial Crisis Anniversary: The Media’s Verdicts

Communication professionals working in finance could draw important lessons from the recent coverage of the financial crisis’ 10th anniversary – it encapsulates the PR problems that have been plaguing the industry for the last decade. Employing our media analytics tools, we examined how the coverage reflected the developments in economics, financial services, personal finances, regulation … Continue reading “Financial Crisis Anniversary: The Media’s Verdicts”

Pharma and Mental Health: Reputation Challenges

Analysing the mental health coverage, we concluded that while the awareness of mental health issues is increasing, pharma’s reputation in this area lags behind: the number of mental health-related articles which mention pharma companies is very limited. In addition, many mental health patient groups suggest that pharma should forge closer relationships with them and that … Continue reading “Pharma and Mental Health: Reputation Challenges”